Creatine and Creatinine Metabolism - Physiological Reviews

July 2000 CREATINE AND CREATININE METABOLISM 1187
encoding guanidinoacetate methyltransferase (GAMT) maps to
human chromosome 19 at band p13.3 and to mouse chromosome
10. Genomics 49: 162–164, 1998.
115. CHANG MC, CHANG CC, AND CHANG JC. Cloning of a creatinase
gene from Pseudomonas putida in Escherichia coli by using an
indicator plate. Appl Environ Microbiol 58: 3437–3440, 1992.
116. CHANUTIN A. The fate of creatine when administered to man.
J Biol Chem 67: 29–41, 1926.
117. CHAPADOS RA, GRUVER EJ, INGWALL JS, MARSH JD, AND
GWATHMEY JK. Chronic administration of cardiovascular drugs:
altered energetics and transmembrane signaling. Am J Physiol
Heart Circ Physiol 263: H1576–H1586, 1992.
118. CHAWLA RK AND JONES DP. Abnormal metabolism of S-adenosyl-L-methionine
in hypoxic rat liver. Similarities to its abnormal
metabolism in alcoholic cirrhosis. Biochim Biophys Acta 1199:
45–51, 1994.
119. CHEN C, PEARSON AM, AND GRAY JI. Meat mutagens. Adv Food
Nutr Res 34: 387–449, 1990.
120. CHEVLI R AND FITCH CD. �-Guanidinopropionate and phosphorylated
�-guanidinopropionate as substrates for creatine kinase.
Biochem Med 21: 162–167, 1979.
121. CHEVREUL. Sur la composition chimique du bouillon de viandes.
J Pharm Sci Access 21: 231–242, 1835.
122. CHIANG PK AND CANTONI GL. Perturbation of biochemical transmethylations
by 3-deazaadenosine in vivo. Biochem Pharmacol
28: 1897–1902, 1979.
123. CHIDA K, TSUNENAGA M, KASAHARA K, KOHNO Y, AND KU-
ROKI T. Regulation of creatine phosphokinase B activity by protein
kinase C. Biochem Biophys Res Commun 173: 346–350, 1990.
124. CHLUMSKY LJ, WILLIE STURGESS A, NIEVES E, AND SCHUMAN
JORNS M. Identification of the covalent flavin attachment site in
sarcosine oxidase. Biochemistry 37: 2089–2095, 1998.
125. CHLUMSKY LJ, ZHANG L, AND JORNS MS. Sequence analysis of
sarcosine oxidase and nearby genes reveals homologies with key
enzymes of folate one-carbon metabolism. J Biol Chem 270:
18252–18259, 1995.
126. CHOU H-C, LANG NP, AND KADLUBAR FF. Metabolic activation
of N-hydroxy arylamines and N-hydroxy heterocyclic amines by
human sulfotransferase(s). Cancer Res 55: 525–529, 1995.
127. CHRISTENSEN M, HARTMUND T, AND GESSER H. Creatine kinase,
energy-rich phosphates and energy metabolism in heart
muscle of different vertebrates. J Comp Physiol B Biochem Syst
Environ Physiol 164: 118–123, 1994.
128. CLARK JF. Creatine and phosphocreatine: a review of their use in
exercise and sport. J Athletic Train 32: 45–51, 1997.
129. CLARK JF, KEMP GJ, AND RADDA GK. The creatine kinase equilibrium,
free [ADP] and myosin ATPase in vascular smooth muscle
cross-bridges. J Theor Biol 173: 207–211, 1995.
130. CLARK JF, KHUCHUA Z, KUZNETSOV AV, VASSIL’EVA E,
BOEHM E, RADDA GK, AND SAKS V. Actions of the creatine
analogue �-guanidinopropionic acid on rat heart mitochondria.
Biochem J 300: 211–216, 1994.
131. COLBERG-POLEY AM, SANTOMENNA LD, HARLOW PP, BEN-
FIELD PA, AND TENNEY DJ. Human cytomegalovirus US3 and
UL36–38 immediate-early proteins regulate gene expression. J Virol
66: 95–105, 1992.
132. COLL M, KNOF SH, OHGA Y, MESSERSCHMIDT A, HUBER R,
MOELLERING H, RÜSSMANN L, AND SCHUMACHER G. Enzymatic
mechanism of creatine amidinohydrolase as deduced from
crystal structures. J Mol Biol 214: 597–610, 1990.
133. COLLISON MW AND THOMAS JA. S-thiolation of cytoplasmic
cardiac creatine kinase in heart cells treated with diamide. Biochim
Biophys Acta 928: 121–129, 1987.
134. CONCONI F AND GRAZI E. Transamidinase of hog kidney. I.
Purification and properties. J Biol Chem 240: 2461–2464, 1965.
135. CONLEY KE AND KUSHMERICK MJ. Buffering work transitions in
myocardium: role of a poorly metabolized creatine analogue.
Magn Res Med 2: 902, 1990.
136. CONNELLY A, VAN PAESSCHEN W, PORTER DA, JOHNSON CL,
DUNCAN JS, AND GADIAN DG. Proton magnetic resonance spectroscopy
in MRI-negative temporal lobe epilepsy. Neurology 51:
61–66, 1998.
137. CONNETT RJ. Analysis of metabolic control: new insights using
scaled creatine kinase model. Am J Physiol Regulatory Integrative
Comp Physiol 254: R949–R959, 1988.
138. CONSTANTIN-TEODOSIU D, GREENHAFF PL, GARDINER SM,
RANDALL MD, MARCH JE, AND BENNETT T. Attenuation by
creatine of myocardial metabolic stress in Brattleboro rats caused
by chronic inhibition of nitric oxide synthase. Br J Pharmacol
116: 3288–3292, 1995.
139. CONWAY MA, BOTTOMLEY PA, OUWERKERK R, RADDA GK,
AND RAJAGOPALAN B. Mitral regurgitation. Impaired systolic
function, eccentric hypertrophy, and increased severity are linked
to lower phosphocreatine/ATP ratios in humans. Circulation 97:
1716–1723, 1998.
140. CONWAY MA AND CLARK JF. Creatine and Creatine Phosphate:
Scientific and Clinical Perspectives. Orlando, FL: Academic,
1996.
141. COOKE WH AND BARNES WS. The influence of recovery duration
on high-intensity exercise performance after oral creatine supplementation.
Can J Appl Physiol 22: 454–467, 1997.
142. COOKE WH, GRANDJEAN PW, AND BARNES WS. Effect of oral
creatine supplementation on power output and fatigue during
bicycle ergometry. J Appl Physiol 78: 670–673, 1995.
143. COOPER AC AND MILLER JR. Progressive muscular dystrophy: a
review. Rev Can Biol 21: 337–351, 1962.
144. CRIM MC, CALLOWAY DH, AND MARGEN S. Creatine metabolism
in men: creatine pool size and turnover in relation to creatine
intake. J Nutr 106: 371–381, 1976.
145. CRIM MC, CALLOWAY DH, AND MARGEN S. Creatine metabolism
in men: urinary creatine and creatinine excretions with creatine
feeding. J Nutr 105: 428–438, 1975.
146. CROSS JH, CONNELLY A, JACKSON GD, JOHNSON CL, NEV-
ILLE BGR, AND GADIAN DG. Proton magnetic resonance spectroscopy
in children with temporal lobe epilepsy. Ann Neurol 39:
107–113, 1996.
147. CUONO CB, MARQUETAND R, KLEIN MB, AND ARMITAGE I.
Critical role of phosphagens in the energy cascade of cutaneous
ischemia and protective action of phosphocreatine analogues in
skin flap survival. Plast Reconstr Surg 101: 1597–1603, 1998.
149. DALY MM. Guanidinoacetate methyltransferase activity in tissues
and cultured cells. Arch Biochem Biophys 236: 576–584, 1985.
150. DALY MM AND SEIFTER S. Uptake of creatine by cultured cells.
Arch Biochem Biophys 203: 317–324, 1980.
151. DANIELSEN S, KILSTRUP M, BARILLA K, JOCHIMSEN B, AND
NEUHARD J. Characterization of the Escherichia coli codBA
operon encoding cytosine permease and cytosine deaminase. Mol
Microbiol 6: 1335–1344, 1992.
152. DAOUK GH, KADDURAH-DAOUK R, PUTNEY S, KINGSTON R,
AND SCHIMMEL P. Isolation of a functional human gene for brain
creatine kinase. J Biol Chem 263: 2442–2446, 1988.
153. DASHWOOD R, YAMANE S, AND LARSEN R. Study of the forces
stabilizing complexes between chlorophylls and heterocyclic
amine mutagens. Environ Mol Mutagen 27: 211–218, 1996.
154. DAVID S, SHOEMAKER M, AND HALEY BE. Abnormal properties
of creatine kinase in Alzheimer’s disease brain: correlation of
reduced enzyme activity and active site photolabeling with aberrant
cytosol-membrane partitioning. Mol Brain Res 54: 276–287,
1998.
155. DAVIDEK J, VELISEK J, KLEIN S, AND JANICEK G. Nitrosierungsprodukte
von Kreatin und Kreatinin in Fleisch. Fleischwirtschaft
99–100, 1976.
156. DAVIES SEC, NEWCOMBE J, WILLIAMS SR, MCDONALD WI, AND
CLARK JB. High resolution proton NMR spectroscopy of multiple
sclerosis lesions. J Neurochem 64: 742–748, 1995.
157. DAVIS BM, MILLER RK, BRENT RL, AND KOSZALKA TR. Maternofetal
transport of creatine in the rat. Biol Neonate 33: 43–54, 1978.
158. DAVIS CD, ADAMSON RH, AND SNYDERWINE EG. Studies on the
mutagenic activation of heterocyclic amines by cynomolgus monkey,
rat and human microsomes show that cynomolgus monkeys
have a low capacity to N-oxidize the quinoxaline-type heterocyclic
amines. Cancer Lett 73: 95–104, 1993.
159. DAVIS CD, GHOSHAL A, SCHUT HAJ, AND SNYDERWINE EG.
Metabolic activation of heterocyclic amine food mutagens in the
mammary gland of lactating Fischer 344 rats. Cancer Lett 84:
67–73, 1994.